Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apheresis for renal disease.

A A Kaplan1

  • 1Department of Medicine, University of Connecticut Health Center, Farmington 06032, USA. kaplan@nso.uchc.edu

Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis
|May 17, 2001
PubMed
Summary

Therapeutic plasma exchange (TPE) effectively removes pathogenic immunoglobulins and autoantibodies, offering a valuable treatment for various kidney diseases, including autoimmune conditions and thrombotic microangiopathies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary study on the impact of 900 MHz radiation on human sperm: An in vitro molecular approach.

Reproductive toxicology (Elmsford, N.Y.)·2024
Same author

Cooley's anemia; a case report.

Northern New York medical journal·2010
Same author

Predictable removal of anticardiolipin antibody by therapeutic plasma exchange (TPE) in catastrophic antiphospholipid antibody syndrome (CAPS).

Clinical nephrology·2008
Same author

Shunt nephritis from Propionibacterium acnes in a solitary kidney.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Role of the nephrologist in the intensive care unit.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
Same author

Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.

Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis·2001

Area of Science:

  • Nephrology
  • Immunology
  • Hematology

Background:

  • Primary renal diseases often involve antibody deposition or autoimmune processes, affecting glomeruli and tubules.
  • Conditions like Goodpasture's syndrome, cryoglobulinemia, ANCA-associated vasculitis, and myeloma light chain nephropathy are linked to immunoglobulin-related kidney damage.
  • Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS), while not classic autoimmune diseases, also impact the kidneys.

Purpose of the Study:

  • To explore the role and efficacy of therapeutic plasma exchange (TPE) in managing renal diseases.
  • To understand the mechanisms by which TPE benefits conditions involving antibody-mediated injury and thrombotic microangiopathies.

Main Methods:

  • Review of existing literature and clinical observations regarding TPE in renal diseases.

Related Experiment Videos

  • Analysis of the immunological and pathophysiological underpinnings of antibody-mediated glomerulonephritis, tubulopathies, TTP, and HUS.

    • Main Results:

    • TPE is effective in rapidly removing nephrotoxic immunoglobulins and autoantibodies from circulation.
    • The treatment has shown significant benefits in managing rapidly progressive glomerulonephritis and myeloma-related kidney injury.
    • TPE is a recognized treatment for TTP and HUS, likely by replacing deficient enzymes or clearing pathogenic autoantibodies.

    Conclusions:

    • Therapeutic plasma exchange is a crucial modality for treating a spectrum of kidney diseases characterized by antibody deposition or autoimmune phenomena.
    • Recent insights suggest TPE's benefit in TTP and HUS stems from enzyme replacement or autoantibody clearance, highlighting its versatile therapeutic action.